2nd Annual Virtual Tumor Board®: Integrating Emerging Testing Methodologies into Optimal Treatment Planning in Gastrointestinal Cancers

Release Date: November 30, 2022

Expiration Date: November 30, 2023

Activity Overview

This online, on-demand virtual webcast brings together renowned experts in gastrointestinal (GI) malignancies. In this educational program, expert faculty examine the application of testing and treatment methodologies across GI malignancies by providing an overview of clinically relevant emerging biomarkers and testing methods used to inform treatment approaches. Following a presentation of the current and emerging biomarkers involved in testing for and treating GI cancers, the experts discuss cases that highlight best practices in biomarker testing to guide treatment for patients with GI malignancies.

This educational activity is an archive of the live virtual webcast held on November 15, 2022.

Target Audience

This educational activity is directed toward medical oncologists, pathologists, nurse practitioners, physician assistants, nurses, and others who treat GI malignancies.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Evaluate relevant biomarkers and molecular testing strategies to guide decision-making in gastrointestinal cancers
• Summarize the relevance of liquid biopsy approaches across gastrointestinal cancers
• Assess efficacy and safety data regarding targeted treatment options in gastrointestinal cancers
• Explain appropriate testing strategies in specific patient case scenarios to optimize management of gastrointestinal malignancies

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC, have no relevant financial relationships with ineligible companies.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.